{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:27:49Z","timestamp":1792931269432,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.radonc.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T03:52:51Z","timestamp":1611028371000},"page":"15-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Modelling of late side-effects following cranial proton beam therapy"],"prefix":"10.1016","volume":"157","author":[{"given":"Almut","family":"Dutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"L\u00fchr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Agolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"B\u00fctof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9550-9050","authenticated-orcid":false,"given":"Esther G.C.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2531-6920","authenticated-orcid":false,"given":"Xavier","family":"Vermeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Geismar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayan","family":"Lamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Lebow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Bussi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian E.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Bussi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-9556","authenticated-orcid":false,"given":"Mechthild","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Timmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7017-3738","authenticated-orcid":false,"given":"Steffen","family":"L\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2021.01.004_b0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2021.01.004_b0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00066-016-1005-9","article-title":"Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma","volume":"192","author":"Harrabi","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2021.01.004_b0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.14338\/IJPT-14-00026.1","article-title":"Comparative proton and photon treatment planning in pediatric patients with various diagnoses","volume":"2","author":"Kristensen","year":"2015","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2021.01.004_b0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/02841860701218626","article-title":"A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; Implications for the long-term morbidity of cancer survivors","volume":"46","author":"Palm","year":"2007","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx208","article-title":"Quality of life and patient-reported outcomes following proton radiation therapy: A systematic review","volume":"110","author":"Verma","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2021.01.004_b0030","unstructured":"Particle Therapy Co-Operative Group. Particle therapy facilities in operation. [cited 2020 May 07], 2020. URL: https:\/\/www.ptcog.ch\/index.php\/facilities-in-operation."},{"key":"10.1016\/j.radonc.2021.01.004_b0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejca.2016.04.008","article-title":"Individual patient information to select patients for different radiation techniques","volume":"62","author":"Quik","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2021.01.004_b0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2015.10.004","article-title":"The quest for evidence for proton therapy: Model-based approach and precision medicine","volume":"95","author":"Widder","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0055","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1118\/1.4762562","article-title":"Brain necrosis after fractionated radiation therapy: Is the halftime for repair longer than we thought?","volume":"39","author":"Bender","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0060","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","article-title":"Radiation dose-volume effects in the brain","volume":"76","author":"Lawrence","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0065","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1016\/j.ijrobp.2011.10.021","article-title":"Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors","volume":"83","author":"Gondi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0070","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0360-3016(00)00493-4","article-title":"Calculation of cranial nerve complication probability for acoustic neuroma radiosurgery","volume":"47","author":"Meeks","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0075","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0360-3016(00)01387-0","article-title":"Hypothalamic\/pituitary function following high-dose conformal radiotherapy to the base of skull: Demonstration of a dose-effect relationship using dose-volume histogram analysis","volume":"49","author":"Pai","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0080","doi-asserted-by":"crossref","first-page":"20140413","DOI":"10.1259\/bjr.20140413","article-title":"Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy","volume":"88","author":"De Marzi","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2021.01.004_b0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13014-015-0501-x","article-title":"Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy","volume":"10","author":"Lee","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0360-3016(97)00029-1","article-title":"Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors","volume":"38","author":"Martel","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0095","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation dose-volume effects of optic nerves and chiasm","volume":"76","author":"Mayo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0100","doi-asserted-by":"crossref","first-page":"20130459","DOI":"10.1259\/bjr.20130459","article-title":"Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours","volume":"86","author":"Batth","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2021.01.004_b0105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.radonc.2016.08.022","article-title":"Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort","volume":"121","author":"Blanchard","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.radonc.2019.09.017","article-title":"Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy","volume":"142","author":"Pedersen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2019.11.013","article-title":"Modelling the risk of radiation induced alopecia in brain tumor patients treated with scanned proton beams","volume":"144","author":"Palma","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0120","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/cncr.29237","article-title":"Proton therapy for low-grade gliomas: results from a prospective trial","volume":"121","author":"Shih","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.01.004_b0125","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijrobp.2014.07.005","article-title":"Spot scanning proton therapy for malignancies of the base of skull: Treatment planning, acute toxicities, and preliminary clinical outcomes","volume":"90","author":"Grosshans","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1748-717X-7-189","article-title":"First experiences in treatment of low-grade glioma grade I and II with proton therapy","volume":"7","author":"Hauswald","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0135","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ijrobp.2011.08.027","article-title":"Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute","volume":"83","author":"Weber","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0140","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3109\/0284186X.2013.818255","article-title":"Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base","volume":"52","author":"Combs","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1468-3083.2001.00229.x","article-title":"The effect of hair loss on quality of life","volume":"15","author":"Williamson","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.radonc.2021.01.004_b0150","unstructured":"DRKS00007670. Proton therapy of brain tumors: Prospective collection of effectiveness and side effects with standard clinical doses (Proto-R-Hirn). German Clinical Trials Center [Internet], Cologne: German Institute of Medical Documentation and Information (Germany), 2008. Identifier DRKS00007670 [registered 2015 Feb 02, cited 2020 May 07], 2015. URL: https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00007670."},{"key":"10.1016\/j.radonc.2021.01.004_b0155","unstructured":"DRKS00008569. Proton therapy of skull base tumors: Prospective collection of effectiveness and side effects with standard clinical doses (Proto-R-Sch\u00e4delbasis). German Clinical Trials Center [Internet], Cologne: German Institute of Medical Documentation and Information (Germany), 2008. Identifier DRKS00008569 [registered 2015 May 21, cited 2020 May 07], 2015. URL: https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00008569."},{"key":"10.1016\/j.radonc.2021.01.004_b0160","unstructured":"DRKS00004384. Register study standard proton therapy WPE- Adults - (ProReg). German Clinical Trials Center [Internet], Cologne: German Institute of Medical Documentation and Information (Germany), 2008. Identifier: DRKS00004384 [registered 2012 Sep 28, cited 2020 May 07] , 2012. URL: https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00004384."},{"key":"10.1016\/j.radonc.2021.01.004_b0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2018.06.036","article-title":"Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours","volume":"130","author":"Dutz","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/nimg.1999.0459","article-title":"Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space","volume":"10","author":"Schmahmann","year":"1999","journal-title":"Neuroimage"},{"key":"10.1016\/j.radonc.2021.01.004_b0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/COC.0b013e318178e4e8","article-title":"A radiation oncologists guide to contouring the hippocampus","volume":"32","author":"Chera","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0180","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.radonc.2013.10.035","article-title":"Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0185","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.radonc.2015.01.016","article-title":"Organs at risk in the brain and their dose-constraints in adults and in children: A radiation oncologist\u2019s guide for delineation in everyday practice","volume":"114","author":"Scoccianti","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2017.12.013","article-title":"The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology","volume":"128","author":"Eekers","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0195","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ijrobp.2004.12.048","article-title":"Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons","volume":"62","author":"No\u00ebl","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0200","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/neuonc\/nov154","article-title":"Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute","volume":"18","author":"Weber","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0205","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2004.04.031","article-title":"Permanent alopecia after cranial irradiation: dose-response relationship","volume":"60","author":"Lawenda","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0210","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.ijrobp.2009.04.096","article-title":"Radiation therapy and hearing loss","volume":"76","author":"Bhandare","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0215","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.ijrobp.2004.08.019","article-title":"Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients","volume":"61","author":"Pan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-8140(02)00173-1","article-title":"Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: Individualized risk estimation","volume":"65","author":"Honor\u00e9","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0225","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/(SICI)1097-0347(199909)21:6<547::AID-HED8>3.0.CO;2-Y","article-title":"Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: a prospective study","volume":"21","author":"Ho","year":"1999","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2021.01.004_b0230","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijrobp.2006.09.017","article-title":"Ototoxicity after radiotherapy for head and neck tumors","volume":"67","author":"Bhandare","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0235","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/hed.20426","article-title":"Permanent unilateral hearing loss after radiotherapy for parotid gland tumors","volume":"28","author":"van der Putten","year":"2006","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2021.01.004_b0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/00223980.1945.9917223","article-title":"A standardized memory scale for clinical use","volume":"19","author":"Wechsler","year":"1945","journal-title":"J Psychol"},{"key":"10.1016\/j.radonc.2021.01.004_b0245","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.radonc.2021.01.004_b0250","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.radonc.2019.12.024","article-title":"Neurocognitive function and quality of life after proton beam therapy for brain tumour patients","volume":"143","author":"Dutz","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2012.07.005","article-title":"Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial","volume":"104","author":"Gulliford","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0265","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1040-8428(01)00143-3","article-title":"Radiotherapy-related fatigue","volume":"41","author":"Jereczek-Fossa","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2021.01.004_b0270","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0885-3924(96)00008-5","article-title":"Frequency and correlates of fatigue in lung cancer patients receiving radiation therapy: Implications for management","volume":"11","author":"Hickok","year":"1996","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.radonc.2021.01.004_b0275","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.radonc.2017.08.008","article-title":"Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy","volume":"126","author":"Ferris","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0280","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1200\/JCO.2011.36.1154","article-title":"Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?","volume":"29","author":"Bower","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0285","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.ijrobp.2011.05.026","article-title":"Severe dry eye syndrome after radiotherapy for head-and-neck tumors","volume":"82","author":"Bhandare","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0290","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ICO.0000000000000038","article-title":"A review of quality of life measures in dry eye questionnaires","volume":"33","author":"Grubbs","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.radonc.2021.01.004_b0295","unstructured":"NCT02824731. Comparison of proton and photon radiotherapy of brain tumors (ProtoChoice-Hirn). ClinicalTrials.gov [Internet], Bethesda (MD): National Library of Medicine (US), 2000 Feb 29. Identifier NCT02824731 [registered 2016 July 07, updated 2019 Feb 18, cited 2020 May 07], 2016. URL: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02824731."},{"key":"10.1016\/j.radonc.2021.01.004_b0300","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.radonc.2014.10.001","article-title":"Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets","volume":"113","author":"Skripcak","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0305","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2018.05.018","article-title":"\u201cRadiobiology of Proton Therapy\u201d: Results of an international expert workshop","volume":"128","author":"L\u00fchr","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0310","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0360-3016(03)00659-X","article-title":"The impact of contouring uncertainty on rectal 3D dose-volume data: Results of a dummy run in a multicenter trial (AIROPROS01-02)","volume":"57","author":"Foppiano","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0315","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.radonc.2011.06.039","article-title":"The effect of delineation method and observer variability on bladder dose-volume histograms for prostate intensity modulated radiotherapy","volume":"101","author":"Rosewall","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0320","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijrobp.2010.10.019","article-title":"Variations in the contouring of organs at risk: test case from a patient with oropharyngeal cancer","volume":"82","author":"Nelms","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0325","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/cncr.10668","article-title":"Radiation-related cranial nerve palsy in patients with nasopharyngeal carcinoma","volume":"95","author":"Lin","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.01.004_b0330","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ijrobp.2010.01.002","article-title":"Radiation-induced cranial nerve palsy: A cross-sectional study of nasopharyngeal cancer patients after definitive radiotherapy","volume":"79","author":"Kong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.004_b0335","first-page":"35","article-title":"Relative biological effectiveness in proton beam therapy \u2013 current knowledge and future challenges","volume":"9","author":"L\u00fchr","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.01.004_b0340","doi-asserted-by":"crossref","first-page":"R419","DOI":"10.1088\/0031-9155\/59\/22\/R419","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer","volume":"59","author":"Paganetti","year":"2014","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2021.01.004_b0345","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1080\/0284186X.2019.1631477","article-title":"Predicting late magnetic resonance image changes in glioma patients after proton therapy","volume":"58","author":"Eulitz","year":"2019","journal-title":"Acta Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021000049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021000049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:13:37Z","timestamp":1759122817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814021000049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":69,"alternative-id":["S0167814021000049"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2021.01.004","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling of late side-effects following cranial proton beam therapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}